EUVIMEDEUVIMED entdecken
Crossref

D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications

Benilde Cosmi, Cristina Legnani, Alessia Libra, Gualtiero Palareti

Polish Archives of Internal Medicine · 2023

DOI: 10.20452/pamw.16604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Archives of Internal Medicine, 2023. Verfasst von Benilde Cosmi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Angiology and Blood Coagulation Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Angiology and Blood Coagula…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Venous Thrombosis, Pulmonary Embolism, COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

D‑Dimers derive from degradation of cross‑linked fibrin by plasmin, and thus their level is a marker of coagulation and fibrinolytic system activation. Guidelines recommend that D‑dimers are determined if the pretest probability (PTP) is low or intermediate, to exclude venous thromboembolism (VTE), either deep vein thrombosis or pulmonary embolism, and to avoid imaging tests. If the PTP is high or D‑dimer level is above the suggested thresholds, imaging is recommended. D‑Dimer assays offer high sensitivity and low specificity, as D‑dimer levels can be above the threshold in several other conditions than thrombosis, and they increase with age. As a result, there have been several proposals to improve the diagnostic accuracy of D‑dimer levels by adjusting the cutoffs according to patient characteristics, such as age, PTP, pregnancy, renal function, or cancer. D‑Dimer levels can also predict clinical severity of COVID‑19, and escalated anticoagulation based on D‑dimer levels can be associated with a lower risk of mortality in patients with severe COVID‑19. Finally, D‑dimer levels have been incorporated in prediction models for recurrent VTE to help identify patients who may benefit from prolonged anticoagulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismVenous ThrombosisPulmonary EmbolismCOVID-19HumansFibrin Fibrinogen Degradation ProductsAnticoagulantsCOVID-19 Testing

Substanzen

fibrin fragment DFibrin Fibrinogen Degradation ProductsAnticoagulants

Autor:innen und Institutionen

  • Angiology and Blood Coagulation Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna…
  • Arianna Foundation, Bologna, Italy
  • Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Zitieren

APA

Cosmi, B., Legnani, C., Libra, A., & Palareti, G. (2023). D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16604

Vancouver

Cosmi B, Legnani C, Libra A, Palareti G. D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications. Polish Archives of Internal Medicine. 2023. doi:10.20452/pamw.16604

BibTeX
@article{Cosmi2023,
  author = {Cosmi, Benilde and Legnani, Cristina and Libra, Alessia and Palareti, Gualtiero},
  title = {D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications},
  journal = {Polish Archives of Internal Medicine},
  year = {2023},
  doi = {10.20452/pamw.16604}
}
Kostenlos starten →